562 related articles for article (PubMed ID: 19120289)
1. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
Suarez-Pinzon WL; Rabinovitch A
Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
Xue S; Wasserfall C; Parker M; McGrail S; McGrail K; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
J Diabetes Complications; 2010; 24(3):163-7. PubMed ID: 19217320
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
Yang Z; Chen M; Carter JD; Nunemaker CS; Garmey JC; Kimble SD; Nadler JL
Biochem Biophys Res Commun; 2006 Jun; 344(3):1017-22. PubMed ID: 16643856
[TBL] [Abstract][Full Text] [Related]
7. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
8. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
[TBL] [Abstract][Full Text] [Related]
9. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
10. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
[TBL] [Abstract][Full Text] [Related]
11. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
12. Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice.
Hettiarachchi KD; Zimmet PZ; Myers MA
J Autoimmun; 2004 Jun; 22(4):287-96. PubMed ID: 15120752
[TBL] [Abstract][Full Text] [Related]
13. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
[TBL] [Abstract][Full Text] [Related]
14. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
15. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
[TBL] [Abstract][Full Text] [Related]
16. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
17. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
18. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
19. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
